These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18830146)

  • 1. In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs.
    Onishi H; Machida Y
    Molecules; 2008 Aug; 13(9):2136-55. PubMed ID: 18830146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
    Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
    Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
    Wang Y; Xin D; Liu K; Zhu M; Xiang J
    Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrug strategy for enhancing drug delivery via skin.
    Fang JY; Leu YL
    Curr Drug Discov Technol; 2006 Sep; 3(3):211-24. PubMed ID: 17311566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of drug delivery systems for macromolecular drugs].
    Takakura Y
    Yakugaku Zasshi; 1996 Jul; 116(7):519-32. PubMed ID: 8831257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextran conjugates in drug delivery.
    Varshosaz J
    Expert Opin Drug Deliv; 2012 May; 9(5):509-23. PubMed ID: 22432550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of dopamine release from poly(aspartamide)-based prodrugs.
    Juriga D; Laszlo I; Ludanyi K; Klebovich I; Chae CH; Zrinyi M
    Acta Biomater; 2018 Aug; 76():225-238. PubMed ID: 29940369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy.
    Huang P; Wang D; Su Y; Huang W; Zhou Y; Cui D; Zhu X; Yan D
    J Am Chem Soc; 2014 Aug; 136(33):11748-56. PubMed ID: 25078892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles as delivery carriers for anticancer prodrugs.
    Fang JY; Al-Suwayeh SA
    Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
    Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
    Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Molecular Recognition Approach To Synthesize Nucleoside Analogue Based Multifunctional Nanoparticles for Targeted Cancer Therapy.
    Wang D; Liu B; Ma Y; Wu C; Mou Q; Deng H; Wang R; Yan D; Zhang C; Zhu X
    J Am Chem Soc; 2017 Oct; 139(40):14021-14024. PubMed ID: 28945366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal targeting delivery systems.
    Yuan ZX; Shang Z; Gu J; He L
    Future Med Chem; 2019 Sep; 11(17):2237-2240. PubMed ID: 31581917
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembly drug conjugates for anticancer treatment.
    Fumagalli G; Marucci C; Christodoulou MS; Stella B; Dosio F; Passarella D
    Drug Discov Today; 2016 Aug; 21(8):1321-9. PubMed ID: 27329268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.
    Bala V; Rao S; Boyd BJ; Prestidge CA
    J Control Release; 2013 Nov; 172(1):48-61. PubMed ID: 23928356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrugs for transdermal drug delivery - trends and challenges.
    Ita KB
    J Drug Target; 2016 Sep; 24(8):671-8. PubMed ID: 26878159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macromolecular prodrugs based on synthetic polyaminoacids: drug delivery and drug targeting in antitumor therapy.
    Cavallaro G; Pitarresi G; Giammona G
    Curr Top Med Chem; 2011; 11(18):2382-9. PubMed ID: 21671863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Click and release: bioorthogonal approaches to "on-demand" activation of prodrugs.
    Ji X; Pan Z; Yu B; De La Cruz LK; Zheng Y; Ke B; Wang B
    Chem Soc Rev; 2019 Feb; 48(4):1077-1094. PubMed ID: 30724944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.